Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,073,713,002
+$327,455,454 QoQ
Shares Held
2,888,888
0.0% QoQ
Ownership
9.76%
of shares outstanding
% of Portfolio
9.64%
of 13F equity value
Holder Rank
#3
of 416 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. KRYS ranks #2 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
This page
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in KRYS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,073,713,002 | 2,888,888 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $746,257,548 | 2,888,888 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $712,226,447 | 2,888,888 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $490,360,973 | 2,777,777 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $365,643,600 | 2,660,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $492,399,300 | 2,731,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $411,831,254 | 2,628,822 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $477,323,070 | 2,622,222 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $446,796,120 | 2,433,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $454,709,901 | 2,555,555 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $318,282,753 | 2,565,555 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $297,604,380 | 2,565,555 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $300,639,211 | 2,560,811 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $140,105,000 | 1,750,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $111,700,200 | 1,410,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $88,867,500 | 1,275,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,584,500 | 1,075,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $66,872,700 | 1,005,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,226,250 | 475,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||